Meeting
2020 Genitourinary Cancers Symposium
Genomic analysis for potential targetable mutations in relapsed and refractory germ cell tumors.
Authors
Sean Q. Kern
Indiana University, Indianapolis, IN
Sean Q. Kern , Lawrence H. Einhorn , Nabil Adra
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 407)
Abstract #
407
Poster Bd #
E6
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Profiling circulating tumor (ct)DNA mutations after panitumumab treatment in patients with refractory metastatic colorectal cancer (mCRC) from the phase III ASPECCT study.
First Author: Michael Boedigheimer
Poster
2016 Gastrointestinal Cancers Symposium
Molecular profiling of appendix-derived pseudomyxoma peritonei (PMP).
First Author: Elizabeth Gleeson
Poster
2014 Genitourinary Cancers Symposium
Molecular profiling of advanced refractory prostate cancer.
First Author: Rebecca A. Feldman
Poster
2021 Genitourinary Cancers Symposium
Comprehensive genomic profiling (CGP) in patients with relapsed/refractory germ cell tumors (GCT).
First Author: Reem Akel